Literature DB >> 29926078

Mendelian Randomization Evidence for Cardiovascular Precision Medicine.

Christopher J O'Donnell1,2,3.   

Abstract

Mesh:

Substances:

Year:  2018        PMID: 29926078     DOI: 10.1001/jamacardio.2018.1543

Source DB:  PubMed          Journal:  JAMA Cardiol            Impact factor:   14.676


× No keyword cloud information.
  3 in total

Review 1.  How Genomics Is Personalizing the Management of Dyslipidemia and Cardiovascular Disease Prevention.

Authors:  Lane B Benes; Daniel J Brandt; Eric J Brandt; Michael H Davidson
Journal:  Curr Cardiol Rep       Date:  2018-10-17       Impact factor: 2.931

2.  Body composition and atrial fibrillation: a Mendelian randomization study.

Authors:  Emmi Tikkanen; Stefan Gustafsson; Joshua W Knowles; Marco Perez; Stephen Burgess; Erik Ingelsson
Journal:  Eur Heart J       Date:  2019-04-21       Impact factor: 35.855

3.  Mendelian randomization evaluation of causal effects of fibrinogen on incident coronary heart disease.

Authors:  Cavin K Ward-Caviness; Paul S de Vries; Kerri L Wiggins; Jennifer E Huffman; Lisa R Yanek; Lawrence F Bielak; Franco Giulianini; Xiuqing Guo; Marcus E Kleber; Tim Kacprowski; Stefan Groß; Astrid Petersman; George Davey Smith; Fernando P Hartwig; Jack Bowden; Gibran Hemani; Martina Müller-Nuraysid; Konstantin Strauch; Wolfgang Koenig; Melanie Waldenberger; Thomas Meitinger; Nathan Pankratz; Eric Boerwinkle; Weihong Tang; Yi-Ping Fu; Andrew D Johnson; Ci Song; Moniek P M de Maat; André G Uitterlinden; Oscar H Franco; Jennifer A Brody; Barbara McKnight; Yii-Der Ida Chen; Bruce M Psaty; Rasika A Mathias; Diane M Becker; Patricia A Peyser; Jennifer A Smith; Suzette J Bielinski; Paul M Ridker; Kent D Taylor; Jie Yao; Russell Tracy; Graciela Delgado; Stella Trompet; Naveed Sattar; J Wouter Jukema; Lewis C Becker; Sharon L R Kardia; Jerome I Rotter; Winfried März; Marcus Dörr; Daniel I Chasman; Abbas Dehghan; Christopher J O'Donnell; Nicholas L Smith; Annette Peters; Alanna C Morrison
Journal:  PLoS One       Date:  2019-05-10       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.